The present invention provides novel solid state forms of azilsartan medoxomil and process for the preparation thereof. The solid state forms of the present invention includes crystalline forms viz. J2 J3 J4 J5 J6 J7 J8 J9 and amorphous forms of azilsartan medoxomil. Further it relates to the pharmaceutical composition and use of the said formulation to treat the conditions in a subject in need thereof.